10x Genomics Q3'26 Results Expected November 5; EPS Estimate (0.27) USD
10x Genomics is scheduled to report Q3'26 results after the market close on November 5. EPS is estimated at (0.27) USD.
Related stories
Array Technologies to Merge With Shoals in an All-Stock Deal
Array Technologies and Shoals will combine in an all-stock transaction.
M impact | EQUITY | Nov 04, 2026, 02:21 PM UTC
Enviri Exits Deutsche Bahn Contract, Expects $19 Million Gain
Enviri released Harsco Rail from its Deutsche Bahn contract after repaying approximately $73 million in advances. The company expects a net gain of approximately $19 million with t
M impact | EQUITY | Nov 04, 2026, 02:09 PM UTC
Alphabet Backs TeraWulf Credit for Anthropic Data Center Project
TeraWulf receives credit backing from Alphabet for its data center project for Anthropic.
M impact | EQUITY | Nov 04, 2026, 02:08 PM UTC
Vivakor Highlights Potential Annual Service Revenue Above $2 Million
Direct Midstream’s conditional agreement to operate 52 New Mexico wells could generate more than $2 million in annual service revenue at targeted operating levels, subject to final
M impact | EQUITY | Nov 04, 2026, 02:08 PM UTC
TeraWulf Gets Google Credit Backing for Anthropic Data Center Project
M impact | EQUITY | Nov 04, 2026, 02:08 PM UTC
TeraWulf Gets Google Credit Backstop for Anthropic Data-Center Project
M impact | EQUITY | Nov 04, 2026, 02:08 PM UTC